These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 17426205)

  • 41. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
    Buck AK; Halter G; Schirrmeister H; Kotzerke J; Wurziger I; Glatting G; Mattfeldt T; Neumaier B; Reske SN; Hetzel M
    J Nucl Med; 2003 Sep; 44(9):1426-31. PubMed ID: 12960187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
    Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
    Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging.
    Prager E; Wehrschuetz M; Bisail B; Woltsche M; Schwarz T; Lanz H; Sorantin E; Aigner RM
    Nuklearmedizin; 2008; 47(1):18-23. PubMed ID: 18278208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
    Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
    Cancer Sci; 2009 Apr; 100(4):753-8. PubMed ID: 19141127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of myocardial washout of
    Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
    Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Cobben DC; van der Laan BF; Maas B; Vaalburg W; Suurmeijer AJ; Hoekstra HJ; Jager PL; Elsinga PH
    J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
    Ng D; Jacobs M; Mantil J
    Clin Nucl Med; 2006 Jul; 31(7):373-5. PubMed ID: 16785800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
    Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
    Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
    Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.
    Morita M; Higuchi T; Achmad A; Tokue A; Arisaka Y; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1672-81. PubMed ID: 24006150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on
    Kaneko Y; Kato H; Matsuo M
    Jpn J Radiol; 2019 Jan; 37(1):88-94. PubMed ID: 30324248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
    Sato N; Inoue T; Tomiyoshi K; Aoki J; Oriuchi N; Takahashi A; Otani T; Kurihara H; Sasaki T; Endo K
    Neuroradiology; 2003 Oct; 45(10):700-7. PubMed ID: 13680026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
    Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
    Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
    Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
    J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.